TAKEDA PHARMACEUTICAL CO LTD (TAK)
Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO
Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO
大腸がんを対象に、Signatera診断システムTMが薬事承認を取得
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
Forrester: Nine In 10 US Marketing Agencies Use AI To Cut Costs At The Expense Of Creativity
21shares Releases 2026 Crypto Market Report: Mid-Year Audit Tracks Bitcoin ETP Inflows, Layer-2 Consolidation, and Real-World Asset Tokenisation
Cloudflare und beehiiv führen KI-Crawling-Kontrollen ein, um unabhängigen Verlagen den Einstieg in das KI-Zeitalter zu erleichtern
Investor presentation
Change in holdings of interested parties/officers - Fox-Wizel Ltd.
DEFA14A filing
Change in holdings of interested parties/officers - Liran Reller